Allogeneic donor availability for hematopoietic stem cell transplantation in children with sickle cell disease-Reference-Cited by-同舟云学术

Allogeneic donor availability for hematopoietic stem cell transplantation in children with sickle cell disease

Published:2015-02-07 Issue:7 Volume:62 Page:1285-1287
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Justus David¹,Perez-Albuerne Evelio²,Dioguardi Jacqueline²,Jacobsohn David²,Abraham Allistair²

Affiliation:

1. School of Medicine and Health Sciences; The George Washington University; Washington District of Columbia

2. Division of Blood and Marrow Transplantation; Children's National Health System; Washington District of Columbia

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.25439/fullpdf

Reference20 articles.

1. Sickle cell anemia: An underappreciated and unaddressed contributor to global childhood mortality;McGann;J Pediatr,2014

2. Impact of bone marrow transplantation for symptomatic sickle cell disease: An interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease;Walters;Blood,2000

3. Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling;Locatelli;Blood,2013

4. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease;Bernaudin;Blood,2007

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dare mighty things for SCD;Blood;2024-06-20

2. Installation of HbG-Makassar by base editing restores hemoglobin function: a transformative therapy for sickle cell disease;2024-03-14

3. Feasibility of peripheral blood stem cell collection from sickle cell trait donors with an intensified G‐CSF regimen;European Journal of Haematology;2023-08-27

4. Transplant for non-malignant disorders: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the role of alternative donors, stem cell sources and graft engineering;Cytotherapy;2023-05

5. A new beginning: can omidubicel emerge as the next, viable alternative donor source?;Therapeutic Advances in Hematology;2023-01